PORT WASHINGTON, N.Y. — Generic manufacturer Rising Pharmaceuticals, a subsidiary of Aceto, has launched its latest product. The company recently introduced its generic of Zoloft (sertraline oral solution, 20 mg/ml).
The drug is indicated to treat major depressive disorder, obsessive e-compulsive disorder, panic disorder, post-traumatic stress disorder, social anxiety disorder and premenstrual dysphoric disorder. The product had U.S. sales of $9.94 million for the 12 months ended June 2017, according to QuintilesIMS data.
Rising currently has 120 products on the market. It also has 50 products pending with the Food and Drug Administrations or awaiting launch totaling more than $12.2 billion in addressable market value, the company said.
October 31, 2017